Maura M. Barry

Maura M. Barry

Auto-generated profile, based on publicly available information

Maura M. Barry

Division of Haematology and Oncology, University of Vermont Medical Center, Burlington, VT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in JMIR Formative Research
Verified
Journal Article
Open access
KTKeenae Tiersma
Keenae Tiersma
MRMira Reichman
Mira Reichman
PPPaula J Popok
Paula J Popok
ZNZoe Nelson
Zoe Nelson
MBMaura Barry
Maura Barry
AVAna-Maria Vranceanu
Ana-Maria Vranceanu
The COVID-19 pandemic has necessitated a rapid shift to web-based or blended design models for both ongoing and future clinical research activities. Research conducted virtually not only has the potential to increase the patient-centeredness of clinical research but may also further widen existing disparities in research participation among underrepresented individuals. In this viewpoint, we discuss practical strategies for quantitative and qualitative remote research data collection based on previous literature and our own ongoing clinical research to overcome challenges presented by the shift to remote data collection. We aim to contribute to and catalyze the dissemination of best practices related to remote data collection methodologies to address the opportunities presented by this shift and develop strategies for inclusive research.

1 January 2022 in JCO Oncology Practice
Verified
Journal Article
Open access
SASteven Ades
Steven Ades
DHDiego Adrianzen Herrera
Diego Adrianzen Herrera
TLTim Lahey
Tim Lahey
ATAlissa A. Thomas
Alissa A. Thomas
SJSakshi Jasra
Sakshi Jasra
CHChris Holmes
Chris Holmes
Cyberattacks targeting health care organizations are becoming more frequent and affect all aspects of care delivery. Cancer care is particularly susceptible to major disruptions because of the potential of immediate and long-term consequences for patients who often rely on timely diagnostic testing and regular administration of systemic therapy in addition to other local treatment modalities to cure or control their diseases. On October 28, 2020, a cyberattack was launched on the University of Vermont Health Network with wide-ranging consequences for oncology, including loss of access to all network intranet servers, e-mail communications, and the electronic medical record (EMR). This review details the immediate challenges faced by hematology and oncology during the cyberattack. The impact and response on inpatient, outpatient, and special patient populations are described. Steps that other academic- and community-based oncology practices can take to lessen the brunt of such an assault are suggested. The two areas of immediate impact after the cyberattack were communications and lack of EMR access. The oncology-specific impact included loss of the individualized EMR chemotherapy plan templates and electronic safeguards built into multistep treatment preparation and delivery. With loss of access to schedules, basic patient information, encrypted communications platforms and radiology, and laboratory and pharmacy services, clinical outpatient care delivery was reduced by 40%. The infusion visit volume dropped by 52% in the first week and new patients could not access necessary services for timely diagnostic evaluation, requiring the creation of command centers to oversee ethical and transparent triage and allocation of systemic therapies and address new patient referrals. This included appropriate transfer of patients to alternate sites to minimize delays. Inpatient care including transitions of care was particularly challenging and addressing patient populations whose survival might be affected by delays in care. Oncology health care leaders and providers should be aware of the potential impact of a cyberattack on cancer care delivery and preventively develop processes to mitigate the impact.

1 August 2022 in JCO Oncology Practice
Verified
Journal Article
Closed access
ACAnusha Chidharla
Anusha Chidharla
AUAudun Utengen
Audun Utengen
DADeanna J. Attai
Deanna J. Attai
EDEmily K. Drake
Emily K. Drake
GLG.J. van Londen
G.J. van Londen
MMMerry J. Markham
Merry J. Markham
The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. Therefore, oncology trainees and professionals continue to strive to stay up-to-date with practice guidelines, research, and skills. Although social media as an educational and professional development tool is no longer completely new to medicine and has been embraced, it is still under-researched in terms of various outcomes. Social media plays several key roles in professional development and academic advancement. We reviewed the literature to evaluate how social media can be used for professional development and academic promotion of oncology professionals.

14 July 2022 in JCO Oncology Practice
Verified
Journal Article
Closed access
NDNarjust Duma
Narjust Duma
MKMaimah Karmo
Maimah Karmo
SPSara Beltrán Ponce
Sara Beltrán Ponce
MBMaura M. Barry
Maura M. Barry
EHElizabeth Henry
Elizabeth Henry
HHHeather M. Hylton
Heather M. Hylton
Despite their increased enrollment into medical school, women still face systemic barriers in medicine, whether in an academic or nonacademic setting. Those from Under-Represented Minority (URM) groups face similar issues, which may affect their desire to enter, pursue, and/or maintain a career in medicine. Social media provides unique opportunities for peer-to-peer support among members of URM communities and for amplification of their voices calling for social justice—here defined as a redistribution of power and the quest for equity in access to opportunities, including access to mentorship, professional development, and timely promotion in academic rank. These issues are relevant to oncologists especially as we strive for diversity, equity, and inclusion and to ensure that our patients have equal access to care, regardless of their circumstances. In this article, we review current literature that highlights issues faced by women and historically URM groups in medicine, particularly in oncology. We also discuss the physician's role as a social justice advocate and the concept of the public physician.

29 October 2024 in Journal of Radiotherapy in Practice
Verified
Journal Article
Open access
PDF file
ACAmy K. Chang
Amy K. Chang
CKChristopher P. Kruglik
Christopher P. Kruglik
GVGabriela F. Sarriera Valentin
Gabriela F. Sarriera Valentin
MBMaura M. Barry
Maura M. Barry
WBWilliam J. Brundage
William J. Brundage
MSMirabelle B. Sajisevi
Mirabelle B. Sajisevi
Introduction: Head and neck squamous cell carcinomas (HNSCCs) are aggressive tumours lacking a standardised timeline for treatment initiation post-diagnosis. Delays beyond 60 days are linked to poorer outcomes and higher recurrence risk. Methods: A retrospective review was conducted on patients over 18 with HNSCC treated with (chemo)radiation at a rural tertiary care centre (September 2020–2022). Data on patient demographics, oncologic characteristics, treatment details and delay causes were analysed using SPSS. Results: Out of 93 patients, 35.5% experienced treatment initiation delays (TTIs) over 60 days. Median TTI was 73 days for delayed cases, compared to 41.5 days otherwise. No significant differences in demographics or cancer characteristics were observed between groups. The primary reasons for the delay were care coordination (69.7%) and patient factors (18.2%). AJCC cancer stage showed a trend towards longer delays in advanced stages. Conclusion: One-third of patients faced delayed TTI, primarily due to care coordination and lack of social support. These findings highlight the need for improved multidisciplinary communication and patient support mechanisms, suggesting potential areas for quality improvement in HNSCC treatment management.

29 April 2021 in JMIR Preprints
Verified
Preprint
Open access
KTKeenae Tiersma
Keenae Tiersma
MRMira Reichman
Mira Reichman
PPPaula J Popok
Paula J Popok
ZNZoe Nelson
Zoe Nelson
MBMaura Barry
Maura Barry
AVAna-Maria Vranceanu
Ana-Maria Vranceanu
UNSTRUCTURED The COVID-19 pandemic has necessitated a rapid shift to web-based or blended design models for both ongoing and future clinical research activities. Research conducted virtually not only has the potential to increase the patient-centeredness of clinical research but may also further widen existing disparities in research participation among underrepresented individuals. In this viewpoint, we discuss practical strategies for quantitative and qualitative remote research data collection based on previous literature and our own ongoing clinical research to overcome challenges presented by the shift to remote data collection. We aim to contribute to and catalyze the dissemination of best practices related to remote data collection methodologies to address the opportunities presented by this shift and develop strategies for inclusive research.